We report a case of Lichen Sclerosus in a 73-year-old man who had been treated for epilepsy with carbamazepine. Lichen sclerosus et atrophicus (LSA), also called lichen sclerosus (LS), is a chronic inflammatory cutaneous condition characterized by white plaques with epidermal atrophy and scarring. To date no cases of LSA has been linked to carbamazepine, although in a few cases lichenoid eruptions but without sclero-atrophy have been described after exposure to this drug. Therefore, to our knowledge, this is the first report of a Lichen sclerosus et atrophicus induced by carbamazepine
HallopeauHLichen palnus atrophicus. Union Med Can 1887; 43:729 in Gahan E Hallopeau's communications on Lichen Scleorus et Atrophicus. Arch Dermatol1954; 99:435–37.
2.
DarierJ. Ann Dermatol Syphiligr (Paris)1982; 3: 833 cited by RookAWilkinsonDS and EblingFJG textbook of Dermatology Blackwell Scientific Publications, Oxford and Edinburgh, 1968.
ChiricozziAZhangSDattolaAGabelliniMChimentiSNisticòSP. Role of Th17 in the pathogenesis of cutaneous inflammatory diseasesJ Biol Regul Homeost Agents2012;26(3):313–8.
6.
ChiricozziAZhangSDattolaACannizzaroMVGabelliniMChimentiSNisticòS. New insights in the pathogenesis of cutaneous autoimmune disorders. J Biol Regul Homeost Agents2012; 26(2): 165–70.
7.
NisticòSPaolilloNMinellaD. Effects of TNF-α and IL-1 β on the activation of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes. Int J Immunopathol Pharmacol2010; 23(4): 1057–72.
8.
FistarolSKItinPH. Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol2013; 14(1):27–47.
9.
YesudianPDSugunendranHBatesCMO'MahonyC. Lichen sclerosus. Int J STD AIDS2005; 16(7):465–73.
10.
FettNWerthVP. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol2011; 64(2):217–28.
11.
FistarolSKItinPH. Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol2013; 14(1):27–47.
12.
YipVLMarsonAGJorgensenALPirmohamedMAlfireviA. HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review. Clin Pharmacol Ther2012; 92(6):757–65.
13.
RobertsDLMarksR. Skin reactions to carbamazepine. Arch Dermatol1981; 117:273–5.
14.
LittJ. Litt's drug eruptions and reactions manual. Seventeenth Edition. London: Informa2011. p. 102–4.
15.
HajnsekSMilavec-PureticVNankovicSPetelin GadzeZFilipcicIBujan KovacAStulhofer BuzinaD. Lichen planus induced by carbamazepine: a case report. Epilepsy Behav2012; 24(2):269–71.
16.
PichlerWJTilchJ. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy2004; 59(8):809–20.
